Evolving role of human papillomavirus as a clinically significant biomarker in head and neck squamous cell carcinoma

References

• Ernster JA, Sciotto CG, O’Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope. 2007;117:2115–2128.
   PubMed Web of Science ®Google Scholar
• Van Dyne EA, Henley SJ, Saraiya M, et al. Trends in human papillomavirus-associated cancers – United States, 1999–2015. MMWR Morb Mortal Wkly Rep. 2018;67:918–924.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–4301.
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.
   PubMed Web of Science ®Google Scholar
• Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010;28:4142–4148.
   PubMed Web of Science ®Google Scholar
• Morshed K. Association between human papillomavirus infection and laryngeal squamous cell carcinoma. J Med Virol. 2010;82:1017–1023.
   PubMed Web of Science ®Google Scholar
• Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer–systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35:747–755.
   PubMed Web of Science ®Google Scholar
• Gillison ML, D’Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407–420.
   PubMed Web of Science ®Google Scholar
• Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–269.
   PubMed Web of Science ®Google Scholar
• Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813–1820.
   PubMed Web of Science ®Google Scholar
• Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus–associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736–747.
   PubMed Web of Science ®Google Scholar
• D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–1956.
   PubMed Web of Science ®Google Scholar
• Westra W, Boy S, el-Mofty SK, et al. Squamous cell carcinoma, HPV-positive. In: El-Naggar AK, Chan JKC, Grandis JR, et al., editors. WHO classification of head and neck tumours lyon IARC. Geneva: World Health Organization; 2017. p. 136–138.
   Google Scholar
• Lydiatt WM, Patel SG, O’Sullivan B, et al. Head and neck cancers-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122–137.
   PubMed Web of Science ®Google Scholar
• Sivars L, Tani E, Nasman A, et al. Human papillomavirus as a diagnostic and prognostic tool in cancer of unknown primary in the head and neck region. Anticancer Res. 2016;36:487–493.
   PubMed Web of Science ®Google Scholar
• Rautava J, Syrjanen S. Biology of human papillomavirus infections in head and neck carcinogenesis. Head Neck Pathol. 2012;6(Suppl 1):S3–15.
   PubMedGoogle Scholar
• zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350.
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–475.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–720.
   PubMed Web of Science ®Google Scholar
• Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4:49–70.
   PubMed Web of Science ®Google Scholar
• Louvanto K, Rautava J, Willberg J, et al. Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One. 2013;8:e53413.
   PubMed Web of Science ®Google Scholar
• Kim SH, Koo BS, Kang S, et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer. 2007;120:1418–1425.
   PubMed Web of Science ®Google Scholar
• Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129–1136.
   PubMed Web of Science ®Google Scholar
• Kessis TD, Slebos RJ, Nelson WG, et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A. 1993;90:3988–3992.
   PubMed Web of Science ®Google Scholar
• Slebos RJ, Lee MH, Plunkett BS, et al. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A. 1994;91:5320–5324.
   PubMed Web of Science ®Google Scholar
• Dyson N, Howley PM, Munger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934–937.
   PubMed Web of Science ®Google Scholar
• Khleif SN, DeGregori J, Yee CL, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A. 1996;93:4350–4354.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Head and Neck Cancers (Version 2.2018).
   Google Scholar
• Lewis JS Jr., Beadle B, Bishop JA, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med. 2018;142:559–597.
   PubMed Web of Science ®Google Scholar
• Krane JF. Role of cytology in the diagnosis and management of HPV-associated head and neck carcinoma. Acta Cytol. 2013;57:117–126.
   PubMed Web of Science ®Google Scholar
• Maniakas A, Moubayed SP, Ayad T, et al. North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma. Oral Oncol. 2014;50:942–946.
   PubMed Web of Science ®Google Scholar
• Shoushtari AN, Rahimi NP, Schlesinger DJ, et al. Survey on human papillomavirus/p16 screening use in oropharyngeal carcinoma patients in the United States. Cancer. 2010;116:514–519.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Vaccarella S, Franceschi S, et al. Comparison of two widely used human papillomavirus detection and genotyping methods, GP5+/6+-based PCR followed by reverse line blot hybridization and multiplex type-specific E7-based PCR. J Clin Microbiol. 2016;54:2031–2038.
   PubMed Web of Science ®Google Scholar
• Hesselink AT, van den Brule AJC, Groothuismink ZMA, et al. Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens. J Clin Microbiol. 2005;43:4868–4871.
   PubMed Web of Science ®Google Scholar
• Hernandez-Prera J, Zhang D, Genden E, et al. Detection of human papilloma virus in non-neoplastic tissue of patients with primary oropharyngeal carcinomas: does a field effect exist? Proceedings of the 103rd United States and Canadian academy of pathology (USCAP) annual meeting. Vol. 94; 2014 Mar 1–8; San Diego, CA. New York: Nature publishing group; p. 319A.
   Google Scholar
• Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465–2472.
   PubMed Web of Science ®Google Scholar
• Snijders PJ, Heideman DA, Meijer CJ. Methods for HPV detection in exfoliated cell and tissue specimens. Apmis. 2010;118:520–528.
   PubMed Web of Science ®Google Scholar
• Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003;201:1–6.
   PubMed Web of Science ®Google Scholar
• Park JS, Hwang ES, Park SN, et al. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol. 1997;65:121–129.
   PubMed Web of Science ®Google Scholar
• Karbalaie Niya MH, Keyvani H, Safarnezhad Tameshkel F, et al. Human papillomavirus type 16 integration analysis by real-time PCR assay in associated cancers. Transl Oncol. 2018;11:593–598.
   PubMed Web of Science ®Google Scholar
• Holzinger D, Schmitt M, Dyckhoff G, et al. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res. 2012;72:4993–5003.
   PubMed Web of Science ®Google Scholar
• Mellin H, Dahlgren L, Munck-Wikland E, et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer. 2002;102:152–158.
   PubMed Web of Science ®Google Scholar
• Uhlig K, Earley A, Lamont J, et al. AHRQ technology assessments. Rockville (MD): Agency for Healthcare Research and Quality; 2013.
   Google Scholar
• Witt BL, Albertson DJ, Coppin MG, et al. Use of in situ hybridization for HPV in head and neck tumors: experience from a national reference laboratory. Head Neck Pathol. 2015;9:60–64.
   PubMed Web of Science ®Google Scholar
• Schlecht NF, Brandwein-Gensler M, Nuovo GJ, et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol. 2011;24:1295–1305.
   PubMed Web of Science ®Google Scholar
• Schache AG, Liloglou T, Risk JM, et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity and prognostic discrimination. Clin Cancer Res off J Am Assoc Cancer Res. 2011;17:6262–6271.
   PubMed Web of Science ®Google Scholar
• Thavaraj S, Stokes A, Guerra E, et al. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol. 2011;64:308–312.
   PubMed Web of Science ®Google Scholar
• Shi W, Kato H, Perez-Ordonez B, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol. 2009;27:6213–6221.
   PubMed Web of Science ®Google Scholar
• Chung CH, Zhang Q, Kong CS, et al. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol. 2014;32:3930–3938.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Nagamura H, Iwamoto KS, et al. RNA from decades-old archival tissue blocks for retrospective studies. Diagn Mol Pathol. 1998;7:202–208.
   PubMedGoogle Scholar
• Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol. 2014;50:771–779.
   PubMed Web of Science ®Google Scholar
• Dok R, Nuyts S. HPV positive head and neck cancers: molecular Pathogenesis and evolving treatment strategies. Cancers (Basel). 2016;8:1–16.
   Web of Science ®Google Scholar
• Rooper LM, Gandhi M, Bishop JA, et al. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization. Oral Oncol. 2016;55:11–16.
   PubMed Web of Science ®Google Scholar
• Parry D, Bates S, Mann DJ, et al. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. Embo J. 1995;14:503–511.
   PubMed Web of Science ®Google Scholar
• Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998;58:5–13.
   PubMed Web of Science ®Google Scholar
• Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166–2173.
   PubMed Web of Science ®Google Scholar
• Jalaly JB, Lewis JS Jr., Collins BT, et al. Correlation of p16 immunohistochemistry in FNA biopsies with corresponding tissue specimens in HPV-related squamous cell carcinomas of the oropharynx. Cancer Cytopathol. 2015;123:723–731.
   PubMed Web of Science ®Google Scholar
• Holmes BJ, Maleki Z, Westra WH. The fidelity of p16 staining as a surrogate marker of human papillomavirus status in fine-needle aspirates and core biopsies of neck node metastases: implications for HPV testing protocols. Acta Cytol. 2015;59:97–103.
   PubMed Web of Science ®Google Scholar
• Xu B, Ghossein R, Lane J, et al. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma. Hum Pathol. 2016;54:193–200.
   PubMed Web of Science ®Google Scholar
• Shelton J, Purgina BM, Cipriani NA, et al. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status. Mod Pathol. 2017;30:1194–1203.
   PubMed Web of Science ®Google Scholar
• Lewis JS Jr., Shelton J, Kuhs KL, et al. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma using the e6h4 antibody clone: a technical method study for optimal dilution. Head Neck Pathol. 2018;12:440–447.
   PubMed Web of Science ®Google Scholar
• Bryant AK, Sojourner EJ, Vitzthum LK, et al. Prognostic role of p16 in nonoropharyngeal head and neck cancer. J Natl Cancer Inst. 2018;110:1393–1399.
   PubMedGoogle Scholar
• Poling JS, Ma XJ, Bui S, et al. Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue. Oral Oncol. 2014;50:306–310.
   PubMed Web of Science ®Google Scholar
• Upile NS, Shaw RJ, Jones TM, et al. Squamous cell carcinoma of the head and neck outside the oropharynx is rarely human papillomavirus related. Laryngoscope. 2014;124:2739–2744.
   PubMed Web of Science ®Google Scholar
• Young RJ, Urban D, Angel C, et al. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma. Br J Cancer. 2015;112:1098–1104.
   PubMed Web of Science ®Google Scholar
• Zafereo ME, Xu L, Dahlstrom KR, et al. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016;56:47–53.
   PubMed Web of Science ®Google Scholar
• Wilson DD, Rahimi AS, Saylor DK, et al. p16 not a prognostic marker for hypopharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2012;138:556–561.
   PubMedGoogle Scholar
• Fakhry C, Westra WH, Wang SJ, et al. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 2017;123:1566–1575.
   PubMed Web of Science ®Google Scholar
• Lassen P, Primdahl H, Johansen J, et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol. 2014;113:310–316.
   PubMed Web of Science ®Google Scholar
• Lingen MW, Xiao W, Schmitt A, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013;49:1–8.
   PubMed Web of Science ®Google Scholar
• Zhao M, Rosenbaum E, Carvalho AL, et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer. 2005;117:605–610.
   PubMed Web of Science ®Google Scholar
• Chuang AY, Chuang TC, Chang S, et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol. 2008;44:915–919.
   PubMed Web of Science ®Google Scholar
• Ahn SM, Chan JY, Zhang Z, et al. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2014;140:846–854.
   PubMed Web of Science ®Google Scholar
• Wang Y, Springer S, Mulvey CL, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci Transl Med. 2015;7:293ra104.
   PubMed Web of Science ®Google Scholar
• Dahlstrom KR, Li G, Hussey CS, et al. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer. 2015;121:3455–3464.
   PubMed Web of Science ®Google Scholar
• Mazurek AM, Rutkowski T, Fiszer-Kierzkowska A, et al. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients. Oral Oncol. 2016;54:36–41.
   PubMed Web of Science ®Google Scholar
• Dahlstrom KR, Anderson KS, Cheng JN, et al. HPV serum antibodies as predictors of survival and disease progression in patients with HPV-positive squamous cell carcinoma of the oropharynx. Clin Cancer Res. 2015;21:2861–2869.
   PubMed Web of Science ®Google Scholar